Gen House
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $31M
Investors
- 9
About Gen House
, trading under the name Gen House, operates as a biotechnology company focusing on the development of small molecule antitumor new drugs. Kuifeng Wang, the company's founder and CEO, graduated from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and is also a candidate for the National Major Talent Project. It has a branch office in Shanghai. The company cooperated with Zhejiang University, Wuxi AppTec, Shanghai Institute of Material Medica, Chinese Academy of Sciences. In 2020, the company reached a cooperation with Huya International to realize commercialization in the early stage of drug development. Gen House mainly engages in the research and development of small molecule antitumor new drugs. The company has established a structural biology research platform, an early drug screening platform, and a preclinical evaluation platform, forming a product pipeline with targeted antitumor products as the core. Its main products include GH35, GH21, GH55 and GH52, etc. GH21 is a small molecule SHP2 inhibitor. The company generates revenue by providing small molecule antitumor new drugs. The company plans to use the latest venture funds to accelerate the research and development of its AI anti-tumor small molecule pipeline, specifically advancing its differentiated programs in the Ras signaling and synthetic lethality fields.
Who invested in Gen House
9 investors across 3 rounds
See all investors in Gen House
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gen House
Who invested in Gen House?
Gen House has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gen House raised?
Gen House has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gen House last raise money?
Gen House's most recent round on record is a Series B, in Feb 2022.
What does Gen House do?
, trading under the name Gen House, operates as a biotechnology company focusing on the development of small molecule antitumor new drugs.
Where is Gen House headquartered?
Gen House is headquartered in Suzhou, China.
Which VCs invest in companies like Gen House?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Gen House's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Gen House? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.